- Home
- NIU vs RNAC Comparison
NIU vs RNAC Comparison
Compare NIU & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- RNAC
- Stock Information
- Founded
- NIU 2014
- RNAC 2007
- Country
- NIU China
- RNAC United States
- Employees
- NIU N/A
- RNAC N/A
- Industry
- NIU Auto Manufacturing
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- RNAC Health Care
- Exchange
- NIU Nasdaq
- RNAC Nasdaq
- Market Cap
- NIU 216.7M
- RNAC 242.4M
- IPO Year
- NIU 2018
- RNAC 2016
- Fundamental
- Price
- NIU $3.36
- RNAC $11.21
- Analyst Decision
- NIU
- RNAC Strong Buy
- Analyst Count
- NIU 0
- RNAC 6
- Target Price
- NIU N/A
- RNAC $41.25
- AVG Volume (30 Days)
- NIU 1.1M
- RNAC 69.2K
- Earning Date
- NIU 08-11-2025
- RNAC 08-07-2025
- Dividend Yield
- NIU N/A
- RNAC N/A
- EPS Growth
- NIU N/A
- RNAC N/A
- EPS
- NIU N/A
- RNAC N/A
- Revenue
- NIU $477,578,753.00
- RNAC $34,173,000.00
- Revenue This Year
- NIU $41.32
- RNAC N/A
- Revenue Next Year
- NIU $24.38
- RNAC N/A
- P/E Ratio
- NIU N/A
- RNAC N/A
- Revenue Growth
- NIU 26.51
- RNAC 31.91
- 52 Week Low
- NIU $1.66
- RNAC $8.46
- 52 Week High
- NIU $4.90
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- NIU 45.79
- RNAC 59.21
- Support Level
- NIU $3.31
- RNAC $10.01
- Resistance Level
- NIU $3.44
- RNAC $11.75
- Average True Range (ATR)
- NIU 0.22
- RNAC 0.71
- MACD
- NIU -0.02
- RNAC 0.16
- Stochastic Oscillator
- NIU 29.63
- RNAC 89.44
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.